Dementia with Lewy bodies: Prevalence, clinical spectrum and natural history

Journal of Neural Transmission, Supplement

Volumn , Issue 60, 2000, Pages 303-314

  Ransmayr, G ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ALZHEIMER DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DIFFERENTIAL DIAGNOSIS; GENETIC RISK; LEWY BODY; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY;

EID: 0034520794     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6301-6_21     Document Type: Conference Paper

References (91)

1. Donepezil for dementia with Lewy bodies: A case study
2. Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease
3. CYP associated with Parkinson's disease but not with dementia with Lewy bodies or Alzheimer's disease
4. Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease
5. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies
6. REM sleep behavior disorder and degenerative dementia: An association likely reflects Lewy body disease
7. EEG findings in dementia with lewy bodies and Alzheimer's disease
8. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease
9. Diffuse Lewy body disease and progressive dementia
10. Dementia and Parkinson's disease associated with diffuse cortical Lewy bodies
11. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases
12. Lewy bodies and progressive dementia: A critical review and meta-analysis
13. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease
14. Diffuse Lewy body disease: Neuropathological and biochemical studies of six patients
15. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD
16. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients
17. Brain perfusion scintigraphy with 99mTc-HMPAO or 99Tc-ECD and 123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease
18. High proportion of dementia with Lewy bodies in the postmortems of a mental hospital in Germany
19. Presenile dementia with Lewy bodies and neurofibrillary tangles
20. The apolipoprotein E allele e4 is over-represented in patients with the Lewy body variant of Alzheimer's disease
21. Clinical and neuropathological findings in Lewy body dementias
22. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: Two subgroups
23. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia)
24. Motor and cognitive function in Lewy body dementia: Comparison with Alzheimer's and Parkinson's diseases
25. Clinical and quantitative pathological correlates of dementia with Lewy bodies
26. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies
27. The Lewy body variant of Alzheimer's disease: A clinical and pathological entity
28. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types: Significance for etiological theories of Alzheimer's disease
29. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: A volumetric MRI study
30. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease
31. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with Lewy bodies
32. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
33. The accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study
34. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathological study of Parkinson's features in Alzheimer's disease
35. Idiopathic parkinsonism with Lewy-type inclusions in cerebral cortex. A case report
36. Progressive dementia with diffuse Lewy-type inclusions in cerebral cortex: A case report
37. Clinical diagnosis of dementia with Lewy bodies in a Japanese Dementia Registry
38. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients
39. Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome?
40. Regional cerebral blood flow difference between dementia with Lewy bodies and AD
41. Clinical features of familial diffuse Lewy body disease
42. The frequency of Lewy bodies in a consecutive autopsy series
43. Dementia with Lewy bodies: Response of delirium-like features to donepezil
44. Psychiatric features in diffuse Lewy body disease: A clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups
45. Lewy bodies in cerebral cortex. Report of three cases
46. Diffuse Lewy body disease in Japan
47. Dementia-parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex
48. A cliniconeuropathological study of the "Lewy body disease"
49. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: A new disease?
50. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease?
51. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases
52. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies
53. Tacrine efficacy in Lewy body dementia
54. Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry
55. Lewy bodies and response to tacrine in Alzheimer's disease
56. Die Lehre vom Tonus und der Bewegung: Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis agitans
57. The frequency of Lewy bodies in a consecutive autopsy series
58. Alzheimer's disease and Lewy body disease: A comparative clinicopathologic study
59. Apolipoprotein E genotype and Lewy body disease
60. Dementia with Lewy bodies: Choline acetyltransferase parallels nucleus basalis pathology
61. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease and dementia with Lewy bodies: A clinicopathologic study
62. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias
63. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease
64. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample
65. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease
66. A population based investigation of Parkinson's disease with and without dementia. Relationship to age and gender
67. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type
68. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT)
69. Consensus guidlines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB)
70. Report of the second dementia with Lewy body international workshop
71. Dementia with Lewy bodies: Reliability and validity of clinical and pathological criteria
72. Familial dementia with Lewy bodies
73. Diffuse intracytoplasmic ganglionic inclusions (lewy type) associated with progressive dementia and quadriparesis in flexion
74. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant
75. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
76. Diffuse Lewy body disease with immediate post-partum onset
77. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types
78. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease
79. Senile dementia of the Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly
80. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution
81. A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types
82. Dementia with Lewy bodies versus pure Alzheimer disease: Differences in cognition, neuropathology, cholinergic dysfunction, an synapse density
83. Cognitive loss in dementia with lewy bodies and Alzheimer disease
84. Apolipoprotein E E4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls
85. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease
86. Contribution à l'ètude de l'anatomie pathologique du locus niger de Soemmering
87. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies
88. Autosomal dominant diffuse Lewy body disease
89. Olanzapine in dementia with Lewy bodies: A clinical study
90. Alzheimer's disease and its Lewy body variant: A clinical analysis of postmortem verified cases
91. Cortical changes in the parkinsonian brain: A contribution to the delineation of "diffuse Lewy body disease"